Research & Development Operations
The pressures of ever-looming patent cliffs and demands for less expensive drugs and medical devices are making product innovation an imperative for Life Sciences companies. While the rewards may be considerable, potential hurdles to R&D operations—among them, increased regulatory scrutiny, pricing issues, skyrocketing development costs, technological change, intellectual property threats, globalization, and fragmented markets--can stymie Life Sciences companies in their efforts to use disruptive innovation to maintain or grow market share.
The professionals in Deloitte’s Life Sciences R&D Operations understand the unique challenges that are confronting today’s R&D organizations. Whether it’s an emerging player seeking an effective growth strategy or an established organization looking to adapt to the changing marketplace, we help our clients transform the value R&D brings to their organization and the marketplace. Our approaches are pragmatic and realistic, and span the continuum from new R&D operating models through portfolio management, data analytics, R&D IT transformation, and regulatory and safety considerations.
Anticipating tomorrow's complex issues and new strategies is a challenge. Stay tuned in with Dbriefs – live webcasts that give you valuable insights on important developments affecting your business. Dbriefs offers live webcasts featuring practical knowledge from Deloitte specialists.